Home / Companies / Diagonal Therapeutics Inc / Trends
Diagonal Therapeutics Inc H-1B trends
Quarterly LCA aggregate trend points for Diagonal Therapeutics Inc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
Diagonal Therapeutics Inc recorded 1 H-1B LCA filings in 2024 Q3.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2024 Q3 | 1 | 1 | 1 | $100,000 | $96,242 | 1 | 100.0% |
Frequently asked questions
- How have H-1B filings for Diagonal Therapeutics Inc changed over time?
- Diagonal Therapeutics Inc recorded 1 H-1B LCA filings in 2024 Q3. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=diagonal+therapeutics+inc&metric=lca_countJSON